$240.46 +1.34 (%) Valeant Pharmaceuticals International Inc - NYSE

May. 28, 2015 | 01:30 PM

Partner Headlines

  1. Actavis, Valeant Up On Bowel-Disease Drug Approvals

    IBD | May. 28, 2015 | 12:07PM EST
  2. Breakout Watch: AbbVie Testing New Buy Point

    IBD | May. 28, 2015 | 11:26AM EST
  3. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  4. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  5. 3 Top IBD 50 Stocks Hit New All-Time Highs

    IBD | May. 21, 2015 | 16:36PM EST
  6. Retail And Oil Stocks Outperform In Quiet Session

    IBD | May. 21, 2015 | 15:02PM EST
  7. Hedge Funds Bet Higher Oil; Long Apple, Short Intel

    IBD | May. 21, 2015 | 11:06AM EST
  8. Bill Ackman Adds Two Positions to Portfolio in 1QFY15

    GuruFocus | May. 19, 2015 | 13:48PM EST
  9. Endo Buying Par Pharma To Become Top Generics Player

    IBD | May. 18, 2015 | 10:38AM EST
  10. John Paulson Buys Actavis, AIG, Valeant, Sells Equinix, Alibaba

    GuruFocus | May. 16, 2015 | 19:49PM EST
  11. U.S. Loves Europe As Pharma, Energy Boost M&A

    IBD | May. 14, 2015 | 17:45PM EST
  12. Stocks Open To Quiet Gains; Williams, Pall And Zebra Spike

    IBD | May. 13, 2015 | 10:44AM EST
  13. Weekly Insider Sells Highlight: VRX, HCA, GPRO, GD

    GuruFocus | May. 11, 2015 | 10:47AM EST
  14. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
  15. Hot No More: Many Top Stocks Hig With Severe Declines

    IBD | Apr. 30, 2015 | 18:22PM EST
  16. Wednesday's After-Hours Movers: Yelp, Glu Mobile And More

    Benzinga | Apr. 29, 2015 | 17:31PM EST
  17. Valeant Beats Q1 Views, Lifts Guidance, Loses CFO

    IBD | Apr. 29, 2015 | 17:13PM EST
  18. Indexes Lower, Near Session Lows As Fed Announcement Nears

    IBD | Apr. 29, 2015 | 13:22PM EST
  19. Valeant Beats Q1 Views, Lifts Guidance, But Loses CFO

    IBD | Apr. 29, 2015 | 10:55AM EST
  20. Weak GDP Data Shakes Up Stocks; Buffalo Wild Folds Its Wings

    IBD | Apr. 29, 2015 | 10:34AM EST
  21. Valeant Posts Upbeat Q1 Results, Lifts Full-Year Forecast

    Benzinga | Apr. 29, 2015 | 07:48AM EST
  22. Twitter's Premature Earnings Release Caps Volatile Session

    IBD | Apr. 28, 2015 | 17:00PM EST
  23. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  24. Submit Questions for Upcoming Q&A With Value Investor Wally Weitz

    GuruFocus | Apr. 24, 2015 | 14:42PM EST
  25. Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Growth

    IBD | Apr. 13, 2015 | 17:17PM EST
  26. The Top Guru-Held Canadian Stocks

    GuruFocus | Apr. 11, 2015 | 23:51PM EST
  27. Big Cap 20 Reflecting Market Leadership

    IBD | Mar. 2, 2015 | 18:44PM EST
  28. IBD 50 Performance Ramps Up; Several Setups Emerge

    IBD | Feb. 27, 2015 | 18:45PM EST
  29. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  30. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  31. Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point

    IBD | Feb. 26, 2015 | 11:51AM EST
  32. Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma Model For SLXP

    Benzinga | Feb. 26, 2015 | 09:22AM EST
  33. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  34. Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target

    Benzinga | Feb. 25, 2015 | 11:31AM EST
  35. Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

    Benzinga | Feb. 24, 2015 | 16:00PM EST
  36. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  37. Firms Bullish On Valeant Following Earnings, Acquisition

    Benzinga | Feb. 24, 2015 | 13:44PM EST
  38. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  39. 4 Pictures Every Valeant-Salix Investor Should See

    Benzinga | Feb. 23, 2015 | 18:59PM EST
  40. Taxes Put U.S. Firms On Sale

    IBD | Feb. 23, 2015 | 18:54PM EST
  41. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD | Feb. 23, 2015 | 18:51PM EST
  42. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  43. Nasdaq Stretches Win Streak To 9 Days

    IBD | Feb. 23, 2015 | 17:03PM EST
  44. Nasdaq Climbs As Apple Stock Hits New High

    IBD | Feb. 23, 2015 | 16:23PM EST
  45. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  46. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  47. JMP Securities Comments On Salix Pharmaceutical's Takeover Valuation

    Benzinga | Feb. 23, 2015 | 14:41PM EST
  48. Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instead Of An Equity Offering

    Benzinga | Feb. 23, 2015 | 14:27PM EST
  49. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  50. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
Trading Center